BIVI

BioVie Inc.

There isn't enough reported data to score BIVI yet.

BIVI Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Unavailable

BIVI's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.

BIVI PE Valuation

BIVI has no meaningful PE right now: it lost money over the past year.

BIVI Forward outlook

There aren't enough analyst estimates for BIVI to show an outlook.

BIVI Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.19 on Nov 12.

There is not enough scenario data to assess BIVI's risk to reward.

BIVI Earnings Per Share

Q4 2023: $-118.00Q1 2024: $-95.00Q2 2026: $-3.05Q3 2026: $-2.75
Q4 2023: $-118.00Q1 2024: $-95.00Q2 2026: $-3.05Q3 2026: $-2.75
QuarterTTM EPSYoY
Q1 2024-$95.00+$69.00
Q4 2023-$118.00+$31.00
Q3 2023-$146.00-$25.00
Q2 2023-$155.00-$49.00

BIVI lost $2.75 per share over the past year, a smaller loss than the year before.

BIVI Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

BIVI Free Cash Flow

Q4 2023: โˆ’$6MQ1 2024: โˆ’$6MQ2 2024: โˆ’$4MQ3 2024: โˆ’$4MQ4 2024: โˆ’$9MQ1 2025: โˆ’$1MQ2 2025: โˆ’$6MQ3 2025: โˆ’$3MQ4 2025: โˆ’$4MQ1 2026: โˆ’$7MQ2 2026: โˆ’$4MQ3 2026: โˆ’$3M
Q4 2023: โˆ’$6MQ1 2024: โˆ’$6MQ2 2024: โˆ’$4MQ3 2024: โˆ’$4MQ4 2024: โˆ’$9MQ1 2025: โˆ’$1MQ2 2025: โˆ’$6MQ3 2025: โˆ’$3MQ4 2025: โˆ’$4MQ1 2026: โˆ’$7MQ2 2026: โˆ’$4MQ3 2026: โˆ’$3M
QuarterFree cash flowYoY
Q3 2026-$2.9M+$118.4K
Q2 2026-$4.1M+$1.5M
Q1 2026-$7.4M-$6.2M
Q4 2025-$4.4M+$4.1M
Q3 2025-$3M+$555.6K
Q2 2025-$5.6M-$1.6M
Q1 2025-$1.3M+$4.6M
Q4 2024-$8.6M-$2.7M

BIVI has burned cash in almost every quarter: โˆ’$19M over the past year, against โˆ’$18M the year before.

BIVI Total Shares

Q4 2023: 381,708Q1 2024: 448,011Q3 2024: 639,836Q4 2024: 2MQ1 2025: 2MQ3 2025: 5MQ4 2025: 8MQ1 2026: 8MQ2 2026: 7MQ3 2026: 8M
Q4 2023: 381,708Q1 2024: 448,011Q3 2024: 639,836Q4 2024: 2MQ1 2025: 2MQ3 2025: 5MQ4 2025: 8MQ1 2026: 8MQ2 2026: 7MQ3 2026: 8M
PeriodChange %Net change
Quarterly+14%+1M shares
1 year+59%+3.1M shares
3 years+2241%+7.9M shares
5 years+5842%+8.1M shares
Available history+15853%+8.2M shares

BIVI has 8M diluted shares, up 59% from a year ago.

BIVI Net Leverage

BIVI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

BIVI Weekly Momentum

MetricValueStatus
RSI41.8Neutral
Stochastic15.4Oversold

BIVI's weekly RSI is 42 (neutral) and its Stochastic is 15 (oversold).

BIVI PE vs Healthcare Sector

BIVI has no meaningful PE right now: it lost money over the past year.

BIVI Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.3613% below
20 week MA$1.5925% below
50 week MA$1.4820% below
100 week MA$5.2477% below
200 week MA$140.699% below

BIVI is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.

BIVI Yearly ROI

YearStart priceEnd priceROI
2020$350.0$1,550.0+343%
2021$1,550.0$501.0-68%
2022$501.0$641.0+28%
2023$641.0$126.0-80%
2024$126.0$21.3-83%
2025$21.3$1.21-94%
2026 YTD$1.21$1.19-1.7%

BIVI has finished three years in a row lower, and it's down 1.7% so far in 2026.

Give your agent the market.

Get API key